Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Obstetrics and Gynaecology
  • Obstetrics and Gynaecology News
  • Are Hormonal...

Are Hormonal Treatments and Vaginal Moisturizers useful for Genitourinary Syndrome of Menopause?

Written By : Dr Pooja N. |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2024-10-20T21:45:15+05:30  |  Updated On 21 Oct 2024 12:14 PM IST
Are Hormonal Treatments and Vaginal Moisturizers useful for Genitourinary Syndrome of Menopause?
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

Recent systematic review published in the Annals of Internal Medicine offers insights into the effectiveness and safety of treatments for genitourinary syndrome of menopause (GSM). Hormones such as vaginal estrogen, vaginal dehydroepiandrosterone (DHEA), and oral ospemifene, as well as vaginal moisturizers, are commonly used to alleviate symptoms of GSM, including vaginal dryness and painful intercourse.

The review, led by Elisheva Danan, MD, MPH, and her colleagues, encompassed 46 randomized controlled trials, with most treatments lasting for 12 weeks or less. However, the safety of long-term use of these therapies remains unclear, particularly regarding the potential risk of uterine cancer with extended use of vaginal estrogen or ospemifene. The findings from the review indicate that hormonal treatments are associated with reduced pain during intercourse and decreased vaginal dryness, while moisturizers are linked to reduced dryness. Vaginal estrogen showed mixed effectiveness in reducing pain during intercourse compared to DHEA or ospemifene, although it outperformed placebo.

The review also highlighted the scarcity of evidence on the benefits of oral DHEA, raloxifene, bazedoxifene, vaginal oxytocin, or vaginal testosterone for the treatment of GSM. Notably, the conclusions drawn from the review have low certainty due to the short duration of most studies and varying definitions of GSM symptoms. Furthermore, the review did not address the association between GSM and recurrent urinary tract infections (UTIs). According to Rachel Rubin, MD, a urologist and sexual medicine specialist, hormones are essential for addressing the root cause of GSM and reducing the risk of recurrent UTIs. Rubin emphasized the link between UTIs and GSM, indicating that the lack of hormones to the tissue due to GSM can lead to recurrent UTIs, underscoring the importance of longer-term safety data for these treatments. In an accompanying editorial, Stephanie Faubion, MD, MBA, raised concerns about the lack of diversity among the patients represented in GSM treatment trials and the exclusion of women with cardiovascular challenges or cancer.

This raises questions about the safety of these treatments for women with specific health conditions, such as cardiovascular risk factors or a history of cancer. Overall, the review provides important insights into the effectiveness of various treatments for GSM but underscores the need for further research, particularly regarding long-term safety and the association between GSM and UTIs.

Key Points

1. The systematic review in the Annals of Internal Medicine evaluates the effectiveness and safety of treatments for genitourinary syndrome of menopause (GSM), including vaginal estrogen, vaginal dehydroepiandrosterone (DHEA), oral ospemifene, and vaginal moisturizers.

2. The review encompasses 46 randomized controlled trials, with most treatments lasting for 12 weeks or less. It highlights the reduced pain during intercourse and decreased vaginal dryness associated with hormonal treatments and moisturizers, but also notes the uncertainty regarding the long-term safety of these therapies, particularly the potential risk of uterine cancer with extended use of vaginal estrogen or ospemifene.

3. Vaginal estrogen, DHEA, and ospemifene show varying effectiveness in reducing pain during intercourse, with vaginal estrogen outperforming placebo, while the evidence on the benefits of oral DHEA, raloxifene, bazedoxifene, vaginal oxytocin, or vaginal testosterone for the treatment of GSM is limited.

4. The review did not address the association between GSM and recurrent urinary tract infections (UTIs), which is highlighted as crucial, emphasizing the link between UTIs and GSM due to the lack of hormones to the tissue, and the importance of longer-term safety data for these treatments.

5. An accompanying editorial raises concerns about the lack of diversity among the patients in GSM treatment trials and the exclusion of women with cardiovascular challenges or cancer, which questions the safety of these treatments for women with specific health conditions.

6. The review provides vital insights into the efficacy of various GSM treatments but underscores the need for further research, particularly regarding long-term safety and the association between GSM and UTIs.

Reference -

Elisheva R. Danan, Catherine Sowerby, Kristen E. Ullman, et al. Hormonal Treatments and Vaginal Moisturizers for Genitourinary Syndrome of Menopause: A Systematic Review. Ann Intern Med.2024;177:1400-1414. [Epub 10 September 2024]. doi:10.7326/ANNALS-24-00610

menopausegenitourinary syndromevaginal drynesstreatment options
Dr Pooja N.
Dr Pooja N.

    She has done her MBBS and later DGO. She is working as a private practitioner.

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 28/May/2025

    Health Bulletin 28/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok